Abstract
Influenza A virus(IAV)poses a global public health concern and remains an imminent threat to human health.Emerging antiviral resistance to the currently approved influenza drugs emphasizes the urgent need for new therapeutic entities against IAV.Allopregnanolone(ALLO)is a natural product that has been approved as an antidepressant drug.In the present study,we repurposed ALLO as a novel inhibitor against IAVs.Mechanistic studies demonstrated that ALLO inhibited virus replication by interfering with the nucleus translocation of viral nucleoprotein(NP).In addition,ALLO showed significant synergistic activity with compound 16,a hemagglutinin inhibitor of IAVs.In summary,we have identified ALLO as a novel influenza virus inhibitor targeting NP,providing a promising candidate that deserves further investigation as a useful anti-influenza strategy in the future.
基金项目
National Natural Science Foundation of China(82104134)
Natural Science Foundation of Shandong Province,China(ZR2020MH383)
Major Basic Program ofNatural Science Foundation of Shandong Province(ZR2021ZD17)
Jinan Independent Training Innovative Team(2021GXRC028)
Open Research Fund Program of the State Key Laboratory of Virology of China(2022IOV003)